More regulatory requirements raise costs for technology companies in Australia, separating those who deal best with changing rules for legal compliance
Uncertain Behring growth, lower vaccine sales and a controversial restructuring plan led to a post-result share price drubbing. Is it all over for CSL?
FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments
Tony Sycamore, Market Analyst, IG shares his technical views on the Nasdaq, ASX200, gold and crude oil
While FY25 results for CAR Group met expectations, upbeat FY26 guidance and a stronger US performance have lifted market sentiment
FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments
Following a weak FY25, and weak FY26 guidance, Cochlear’s outlook rests on the success of its new Nexa implant and other products. Is the market too confident?
Michael Gable of Fairmont Equities suggests shares in Newmont Corp are ready for their next leg upwards
FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments
Telstra is guiding to subdued mobile growth in FY26 as the cost of living bites. Earnings growth relies on cost cutting and satellite development
